-
EP4256344
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4256344
| EP4256344 - METHOD OF DETERMINING RESISTANCE TO CHECKPOINT INHIBITOR THERAPIES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.09.2023 Database last updated on 13.07.2024 | |
| Former | The international publication has been made Status updated on 14.06.2022 | Most recent event Tooltip | 09.02.2024 | Change: Validation states | published on 13.03.2024 [2024/11] | 09.02.2024 | Change - extension states | published on 13.03.2024 [2024/11] | Applicant(s) | For all designated states Shattuck Labs, Inc. 500 W. 5th Street, Suite 1200 Austin, TX 78701 / US | [2023/41] | Inventor(s) | 01 /
SCHREIBER, Taylor Austin, TX 78701 / US | 02 /
FROMM, George Austin, TX 78701 / US | 03 /
DE SILVA, Suresh Austin, TX 78701 / US | [2023/41] | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
| Former [2023/41] | Sagittarius IP Marlow International Parkway Marlow, SL7 1YL / GB | Application number, filing date | 21901537.7 | 03.12.2021 | [2023/41] | WO2021US61834 | Priority number, date | US202063121083P | 03.12.2020 Original published format: US 202063121083 P | US202163173090P | 09.04.2021 Original published format: US 202163173090 P | US202163215735P | 28.06.2021 Original published format: US 202163215735 P | US202163276066P | 05.11.2021 Original published format: US 202163276066 P | [2023/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2022120187 | Date: | 09.06.2022 | Language: | EN | [2022/23] | Type: | A2 Application without search report | No.: | EP4256344 | Date: | 11.10.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.06.2022 takes the place of the publication of the European patent application. | [2023/41] | Search report(s) | International search report - published on: | US | 18.08.2022 | Classification | IPC: | G01N33/574, A61K39/395, A61P31/00 | [2023/41] | CPC: |
C07K14/705 (EP,IL);
A61K38/1774 (KR,US);
C12Q1/6886 (US);
A01K67/0275 (US);
A61K38/177 (EP,IL);
A61K38/191 (EP,IL,KR,US);
A61K49/0004 (US);
A61P35/00 (US);
C07K14/525 (EP,IL);
G01N33/5088 (US);
G01N33/57484 (EP,IL,KR,US);
G01N33/6863 (EP,IL,KR);
A01K2207/12 (US);
A01K2227/105 (US);
A01K2267/0331 (US);
A61B10/0045 (US);
C07K2319/30 (US);
C12Q2600/106 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/41] | Title | German: | VERFAHREN ZUR BESTIMMUNG DER RESISTENZ GEGEN CHECKPOINT-INHIBITOR-THERAPIEN | [2023/41] | English: | METHOD OF DETERMINING RESISTANCE TO CHECKPOINT INHIBITOR THERAPIES | [2023/41] | French: | PROCÉDÉ DE DÉTERMINATION DE LA RÉSISTANCE À DES THÉRAPIES À INHIBITEUR DE POINT DE CONTRÔLE | [2023/41] | Entry into regional phase | 29.06.2023 | National basic fee paid | 29.06.2023 | Search fee paid | 29.06.2023 | Designation fee(s) paid | 29.06.2023 | Examination fee paid | Examination procedure | 29.06.2023 | Examination requested [2023/41] | 03.01.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 28.12.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2005074633 (UNIV MICHIGAN [US], et al) [A] 1-4,7 * ; entire document *; | [X]US2019256924 (VOGELSTEIN BERT [US], et al) [X] 1-4,7 * ; claim 1, paragraph 0007, 0119, 0121, 0675, 0772, 0779. 0780, 0842, *; | [A] - BERGER, MF et al., "The emerging clinical relevance of genomics in cancer medicine", Nature Reviews Clinical Oncology, (20190725), vol. 15, no. 6, doi:10.1038/s41571-018-0002-6, pages 353 - 365, XP036507280 [A] 1-4,7 DOI: http://dx.doi.org/10.1038/s41571-018-0002-6 |